
Plexision
Plexision developing cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.
About
Plexision developing cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders.
Key facts
At-a-glance profile data
- Website
- plexision.com
- Headquarters
- San Francisco, United States
- Founded
- 2019
- Employees
- 11
- Total funding
- $2M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 24 Jan 2025 | Seed | $365K | Pittsburgh Life Sciences Greenhouse |
| 1 May 2019 | Undisclosed round | $2M | - |
Tech stack
Detected on plexision.com, last scanned 17 Sept 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS, Bootstrap
- Analytics
- Google Analytics 4, Segment
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Plexision raised?
Plexision has raised a total of $2M in funding. The most recent round on record is Seed.
How many employees does Plexision have?
Plexision has approximately 11 people on record.